查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1981015

全球止血和組織密封劑市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Hemostasis and Tissue Sealing Agents Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 168 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計止血和組織黏合劑市場將從 2025 年的 63.4 億美元成長到 2034 年的 141.7 億美元，2026 年至 2034 年的複合年成長率為 9.34%。

受全球外科手術數量不斷增加的推動，全球止血劑和組織黏合劑市場正經歷強勁成長。這些產品廣泛用於術中止血、組織黏合和促進創傷治療。它們常用於心血管外科、整形外科、神經外科和普通外科手術，以改善手術效果並減少併發症。

外科產品和生物材料的技術進步在市場發展中發揮著至關重要的作用。現代止血劑和密封劑旨在實現快速凝血和改善組織黏附。這些產品正日益受到外科醫生的青睞，因為它們有助於最大限度地減少出血、縮短手術時間並加速患者康復。

隨著全球對微創手術的需求持續成長，預計市場將進一步擴大。新興國家醫療基礎設施的改善和手術數量的增加也促進了市場擴張。生物相容性材料和手術技術的不斷創新將支持該領域的長期發展。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球止血與組織密封劑市場：依產品分類

  • 市場分析、洞察與預測
  • 局部止血劑
  • 黏合劑和組織密封膠
  • 防沾黏產品

第5章 全球止血與組織密封劑市場：依材料分類

  • 市場分析、洞察與預測
  • 明膠局部止血劑
  • 膠原蛋白局部止血劑
  • 基於ORC的局部止血劑
  • 基於多醣的局部止血劑

第6章 全球止血與組織密封劑市場：依應用領域分類

  • 市場分析、洞察與預測
  • 一般外科
  • 神經外科
  • 血管外科
  • 心血管外科
  • 其他

第7章 全球止血與組織密封劑市場：依最終用途分類

  • 市場分析、洞察與預測
  • 醫院
  • 門診手術中心
  • 其他

第8章 全球止血與組織密封劑市場：按地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第9章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第10章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Johnson & Johnson
    • CryoLife Inc
    • Advance Medical Solution（AMS）Group Plc
    • Cohera Medical Inc
    • Integra Life Sciences Corporation
    • Pfizer Inc
    • BD
    • Cohesion Technologies Inc
    • HyperBranch Medical Technology
    • Biomet Inc
    • Braun Medical Inc
    • Smith & Nephew
簡介目錄
Product Code: VMR112115538

The Hemostasis and Tissue Sealing Agents Market size is expected to reach USD 14.17 Billion in 2034 from USD 6.34 Billion (2025) growing at a CAGR of 9.34% during 2026-2034.

The global hemostasis and tissue sealing agents market is experiencing strong growth due to the rising number of surgical procedures performed worldwide. These agents are widely used to control bleeding, seal tissues, and enhance wound healing during surgeries. They are commonly applied in cardiovascular, orthopedic, neurological, and general surgical procedures to improve surgical outcomes and reduce complications.

Technological advancements in surgical products and biomaterials are playing a key role in market development. Modern hemostatic agents and sealants are designed to provide rapid clot formation and improved tissue adhesion. Surgeons increasingly prefer these products as they help minimize blood loss, reduce surgical time, and improve patient recovery.

The market is expected to grow further as the demand for minimally invasive surgeries continues to rise globally. Increasing healthcare infrastructure development and growing surgical volumes in emerging economies are also contributing to market expansion. Continuous innovation in biocompatible materials and surgical technologies will support long-term growth in this sector.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

  • Topical Hemostat
  • Adhesive & Tissue Sealant
  • Adhesion Barrier Products

By Material

  • Gelatin-Based Topical Hemostats
  • Collagen-Based Topical Hemostats
  • ORC-Based Topical Hemostats
  • Polysaccharide-Based Topical Hemostats

By Application

  • General Surgery
  • Neurosurgery
  • Vascular Surgery
  • Cardiovascular Surgery
  • Others

By End-use

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

COMPANIES PROFILED

  • Johnson Johnson, CryoLife Inc, Advance Medical Solution AMS Group Plc, Cohera Medical Inc, Integra Life Sciences Corporation, Pfizer Inc, BD, Cohesion Technologies Inc, HyperBranch Medical Technology, Biomet Inc, Braun Medical Inc, Smith Nephew
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Topical Hemostat Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Adhesive & Tissue Sealant Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Adhesion Barrier Products Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET: BY MATERIAL 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Material
  • 5.2. Gelatin-Based Topical Hemostats Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Collagen-Based Topical Hemostats Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. ORC-Based Topical Hemostats Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Polysaccharide-Based Topical Hemostats Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Application
  • 6.2. General Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Neurosurgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Vascular Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Cardiovascular Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET: BY END-USE 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast End-use
  • 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET: BY REGION 2022-2034(USD MN)

  • 8.1. Regional Outlook
  • 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.2.1 By Product
    • 8.2.2 By Material
    • 8.2.3 By Application
    • 8.2.4 By End-use
    • 8.2.5 United States
    • 8.2.6 Canada
    • 8.2.7 Mexico
  • 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.3.1 By Product
    • 8.3.2 By Material
    • 8.3.3 By Application
    • 8.3.4 By End-use
    • 8.3.5 United Kingdom
    • 8.3.6 France
    • 8.3.7 Germany
    • 8.3.8 Italy
    • 8.3.9 Russia
    • 8.3.10 Rest Of Europe
  • 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.4.1 By Product
    • 8.4.2 By Material
    • 8.4.3 By Application
    • 8.4.4 By End-use
    • 8.4.5 India
    • 8.4.6 Japan
    • 8.4.7 South Korea
    • 8.4.8 Australia
    • 8.4.9 South East Asia
    • 8.4.10 Rest Of Asia Pacific
  • 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.5.1 By Product
    • 8.5.2 By Material
    • 8.5.3 By Application
    • 8.5.4 By End-use
    • 8.5.5 Brazil
    • 8.5.6 Argentina
    • 8.5.7 Peru
    • 8.5.8 Chile
    • 8.5.9 South East Asia
    • 8.5.10 Rest of Latin America
  • 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.6.1 By Product
    • 8.6.2 By Material
    • 8.6.3 By Application
    • 8.6.4 By End-use
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE
    • 8.6.7 Israel
    • 8.6.8 South Africa
    • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

  • 9.1. Recent Developments
  • 9.2. Company Categorization
  • 9.3. Supply Chain & Channel Partners (based on availability)
  • 9.4. Market Share & Positioning Analysis (based on availability)
  • 9.5. Vendor Landscape (based on availability)
  • 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1 Johnson & Johnson
    • 10.2.2 CryoLife Inc
    • 10.2.3 Advance Medical Solution (AMS) Group Plc
    • 10.2.4 Cohera Medical Inc
    • 10.2.5 Integra Life Sciences Corporation
    • 10.2.6 Pfizer Inc
    • 10.2.7 BD
    • 10.2.8 Cohesion Technologies Inc
    • 10.2.9 HyperBranch Medical Technology
    • 10.2.10 Biomet Inc
    • 10.2.11 Braun Medical Inc
    • 10.2.12 Smith & Nephew